Oregon Health & Science University's Center for Health & Healing is a 412,000-square-foot medical building in the South Waterfront district of Portland, Oregon. It is connected to the main OHSU campus by the Portland Aerial Tram.

During the past decade, OHSU Center for Health and Healing conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 13 clinical trials were completed, i.e. on average, 108.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 10 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OHSU Center for Health and Healing" #1 sponsor was "Pfizer" with 10 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Oregon Health and Science University" with 4 trials sponsored, "Ipsen" with 2 trials sponsored and "Curium US LLC" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OHSU Center for Health and Healing" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Galderma R&D" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "OHSU Center for Health and Healing" are "Atopic Dermatitis" (6 trials), "Cervical Dystonia" (2 trials), "Transthyretin (TTR) Amyloid Cardiomyopathy" (2 trials), "Alopecia Areata" (1 trials) and "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "OHSU Center for Health and Healing" in a lesser frequency.

Most popular intervention types in "OHSU Center for Health and Healing" are "Drug" (17 trials), "Biological" (4 trials), "Other" (4 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baricitinib" (3 trials), "MEK162" (3 trials), "Botulinum toxin type A" (2 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "OHSU Center for Health and Healing" are 21 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "OHSU Center for Health and Healing". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in OHSU Center for Health and Healing, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in OHSU Center for Health and Healing, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".